[ICU acquired neuromyopathy].

G. Gueret; Maïté Guillouët; V. Vermeersch; E. Guillard; Hélène Talarmin; B.-V. Nguyen; François Rannou; M.-A. Giroux-Metges; J.-P. Pennec; Y. Ozier

doi:10.1016/j.annfar.2013.05.011

Journal articles

[ICU acquired neuromyopathy].

G. Gueret ¹ Maïté Guillouët ¹ V. Vermeersch ¹ E. Guillard ² Hélène Talarmin ² B.-V. Nguyen François Rannou ¹ M.-A. Giroux-Metges ¹ J.-P. Pennec ¹ Y. Ozier ³

1 MUST

M2S - Laboratoire Mouvement Sport Santé

2 M2S - Laboratoire Mouvement Sport Santé

3 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

Abstract : ICU acquired neuromyopathy (IANM) is the most frequent neurological pathology observed in ICU. Nerve and muscle defects are merged with neuromuscular junction abnormalities. Its physiopathology is complex. The aim is probably the redistribution of nutriments and metabolism towards defense against sepsis. The main risk factors are sepsis, its severity and its duration of evolution. IANM is usually diagnosed in view of difficulties in weaning from mechanical ventilation, but electrophysiology may allow an earlier diagnosis. There is no curative therapy, but early treatment of sepsis, glycemic control as well as early physiotherapy may decrease its incidence. The outcomes of IANM are an increase in morbi-mortality and possibly long-lasting neuromuscular abnormalities as far as tetraplegia.

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Tissues and Organs [q-bio.TO]

Complete list of metadatas

https://hal.univ-brest.fr/hal-00881574
Contributor : Jean-Pierre Pennec <>
Submitted on : Friday, November 8, 2013 - 2:56:05 PM
Last modification on : Thursday, January 14, 2021 - 11:16:26 AM

[ICU acquired neuromyopathy].

Identifiers

Collections

Citation

Export

Metrics

235

[ICU acquired neuromyopathy].

Identifiers

Collections

Citation

Export

Share

Metrics

235